Early Phase Clinical Unit (EPCU) - PAREXEL — Glendale, California

Early Phase Clinical Unit (EPCU) - PAREXEL is a clinical research site located in Glendale, California, United States 91206.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Early Phase Clinical Unit (EPCU) - PAREXEL has participated in 1 clinical trials.

Therapeutic areas: Chemotherapy-induced Diarrhea.

Sponsors: Guangzhou Zhiyi Biotechnology Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Early Phase Clinical Unit (EPCU) - PAREXEL?

Early Phase Clinical Unit (EPCU) - PAREXEL has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Early Phase Clinical Unit (EPCU) - PAREXEL conducted?

Early Phase Clinical Unit (EPCU) - PAREXEL has 1 clinical trials on record. Their work covers Chemotherapy-induced Diarrhea.

Is Early Phase Clinical Unit (EPCU) - PAREXEL accredited by Crixeo Health?

Early Phase Clinical Unit (EPCU) - PAREXEL has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Early Phase Clinical Unit (EPCU) - PAREXEL?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.